Literature DB >> 5057368

Influence of mouse strain on the assayed potency (unitage) of tetanus toxoid.

M C Hardegree, M Pittman, C J Maloney.   

Abstract

The assayed potency of an adsorbed tetanus toxoid C(2), relative to the international standard for tetanus toxoid (adsorbed), varied significantly with the use of different strains of mice. The unitage was highest with NIH mice, and it was not significantly different from that with CFW mice. With CDF(1) and BALB/c mice, however, the assayed potency was significantly lower than with NIH mice. C3H mice failed to respond to the dose range of the toxoids employed with the other four strains. The significance of the influence of the mouse strain on the designation of a prescribed unit requirement for tetanus toxoid, adsorbed, relative to human efficacy is discussed.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5057368      PMCID: PMC380557          DOI: 10.1128/am.24.1.120-126.1972

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  24 in total

1.  Differences in primary and secondary immunizability of inbred mice strains.

Authors:  J IPSEN
Journal:  J Immunol       Date:  1959-10       Impact factor: 5.422

2.  Control of potency and the dosage of diphtheria and tetanus toxoids.

Authors:  L GREENBERG; R BENOIT
Journal:  J Am Med Assoc       Date:  1956-01-14

3.  Relationship of the anaphylaxis sensitizing and adjuvant properties of Hemophilus pertussis vaccine.

Authors:  L S KIND
Journal:  J Immunol       Date:  1957-09       Impact factor: 5.422

4.  Passive anaphylaxis in mice with gamma G antibodies. IV. Strain differences in susceptibility to mast cell sensitization in vitro.

Authors:  N M Vaz; Z Ovary
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

5.  Tetanus in the United States (1965-1966):epidemiologic and clinical features.

Authors:  F M LaForce; L S Young; J V Bennett
Journal:  N Engl J Med       Date:  1969-03-13       Impact factor: 91.245

6.  [Strain-dependent differences in the specificity of antibody responses toward lysozyme].

Authors:  E Mozes; E Maron; R Arnon; M Sela
Journal:  J Immunol       Date:  1971-03       Impact factor: 5.422

7.  Immunization against neonatal tetanus in New Guinea. 3. The toxin-neutralization test and the response of guinea-pigs to the toxoids as used in the immunization schedules in New Guinea.

Authors:  M F Barile; M C Hardegree; M Pittman
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

8.  Immunization against neonatal tetanus in New Guinea. Antitoxin response of pregnant women to adjuvant and plain toxoids.

Authors:  R MacLennan; F D Schofield; M Pittman; M C Hardegree; M F Barile
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

9.  International standard for tetanus toxoid.

Authors:  L GREENBERG
Journal:  Bull World Health Organ       Date:  1953       Impact factor: 9.408

10.  Consistency in potency assay of tetanus toxoid in mice.

Authors:  H COHEN; J VAN RAMSHORST; A TASMAN
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

View more
  2 in total

Review 1.  The development and use of vaccine adjuvants.

Authors:  Robert Edelman
Journal:  Mol Biotechnol       Date:  2002-06       Impact factor: 2.695

2.  Comparative analysis of antigenic strength and in vivo serum antibodies concentration of tetanus toxoid vaccine adsorbed in Pakistan.

Authors:  Asif Shah Zahid; Hafiz Muhammad Umer Farooqi; Ali Ahsan; Muhammad Awais Farooqi; Farzana Kausar; Javed Muhammad; Ashfaq Ahmad
Journal:  Saudi J Biol Sci       Date:  2022-06-07       Impact factor: 4.052

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.